Clinical Trials Directory

Trials / Sponsors / Respirent Pharmaceuticals Co Ltd.

Respirent Pharmaceuticals Co Ltd.

Industry · 20 registered clinical trials.

StatusTrialPhaseStarted
UnknownBioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt
Bioequivalence
Phase 12023-08-22
UnknownBioequivalence Study for Fluticasone Propionate 250 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt
Bioequivalence
Phase 12023-08-01
UnknownBioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healt
Bioequivalence
Phase 12023-02-17
UnknownBioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation
Asthma
Phase 32023-01-30
UnknownA Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmac
Asthma, Bioequivalence
Phase 12022-05-11
UnknownBioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respi
Bioequivalence, Asthma
Phase 12021-10-01
UnknownA Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmac
Asthma, Bioequivalence
Phase 12021-08-13
UnknownA Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde
Bioequivalence, Asthma
Phase 12021-01-18
CompletedA Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral
Asthma
Phase 32020-12-09
CompletedA Pivotal Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalati
Bioequivalence
Phase 12020-09-22
CompletedA Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation
Bioequivalence
Phase 12020-09-01
CompletedA Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation
Bioequivalence
Phase 12020-08-24
CompletedA Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalati
Bioequivalence
Phase 12020-07-01
CompletedA Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Char
Bioequivalence
Phase 12019-10-01
CompletedPooled Analysis FP_SX_250_50
Asthma
—2019-06-02
CompletedA Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde
Bioequivalence
Phase 12019-05-21
CompletedA Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. SERETIDE DISKUS® in Healthy Volunteers Wit
Bioequivalence
Phase 12019-03-12
CompletedA Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powde
Bioequivalence
Phase 12019-01-23
CompletedA Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers
Bioequivalence
Phase 12018-11-20
CompletedA Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeter
Asthma
Phase 32018-10-02